CPX-351 and allogeneic stem cell transplant for a therapy-related acute myeloid leukemia that developed after treatment of acute promyelocytic leukemia: a case report and review of the literature

CPX-351 and allogeneic stem cell transplant for a therapy-related acute myeloid leukemia that developed after treatment of acute promyelocytic leukemia: a case report and review of the literature

Therapy-related myeloid neoplasms (t-MNs), which develop after cytotoxic, radiation, or immunosuppressive therapy for an unrelated disease, account for 7%–8% of acute myeloid leukemia (AML). Worse outcomes and consequently shortened survival are associated with t-MNs as compared with de novo AML. Th...

Full description

Bibliographic Details
Main Authors: Alessandra Sperotto, Maria Teresa Lupo Stanghellini, Jacopo Peccatori, Roberta De Marchi, Simona Piemontese, Giulia Ciotti, Marco Basso, Elisabetta Pierdomenico, Paolo Fiore, Fabio Ciceri, Michele Gottardi
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-01-01
Series:Frontiers in Oncology
Subjects:
acute promyelocytic leukemia
therapy-related myeloid neoplasm
allogeneic hematopoietic stem cell transplantation
CPX-351
acute myeloid leukemia
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1291457/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1291457/full

Similar Items